Access cutting-edge early alzheimer's disease treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access early alzheimer's disease specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related early alzheimer's disease treatment provided free
The purpose of this study is to measure the difference in time to developing or worsening memory, thinking, or functional problems due to Alzheimer's disease occurring in participants receiving study drug compared to placebo. Participation could last up to 255 weeks including screening, a double-blind treatment period, and a double-blind observation period. In addition, eligible participants who receive placebo during the double-blind treatment period may choose to extend their study participat
Sponsor: Eli Lilly and Company
Check if you qualify for this early alzheimer's disease clinical trial in Phoenix, AZ
If you're searching for early alzheimer's disease treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced early alzheimer's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.